Nucleic acid based risk assessment and staging for clinical practice in multiple myeloma.
The recently introduced Revised International Staging System (R-ISS) for multiple myeloma (MM) integrates albumin, β2 microglobulin, lactate dehydrogenase (LDH) with high-risk cytogenetic aberrations (CA), i.e., t(4;14) and t(14;16) and del17p using fluorescent in situ hybridization (FISH). We evalu...
| Published in: | Annals of Hematology Vol. 97; no. 12; pp. 2447 - 2455 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | research tables/charts Journal Article |
| Published: |
Springer Nature
Dec2018
|
| Online Access: | View this record in EBSCOhost |